New research explores the risks and benefits of SSRI use during pregnancy, highlighting a link to gestational diabetes and ...

Researchers propose "exercise mimetics" (exercise pills) to treat depression by hacking the muscle-brain axis for those unable to physically exercise.

HELUS Pharma has rebranded and moved to Nasdaq, signaling a shift toward late-stage clinical development and commercial focus ...

The presentation by Dr. Dirk Beher, Chief Executive Officer of FundaMental Pharma, will highlight the scientific foundation for lead candidate FMP374, the distinctive approach to modulating NMDAR, and ...

Clinical trials are showing that DMT — the psychedelic compound in ayahuasca — can produce rapid antidepressant effects in a ...

A weeklong, high-intensity version of TMS may work nearly as well as the standard six-week treatment for depression. In a UCLA study, patients who received five sessions a day for five days ...

A Phase 2 trial at Imperial College London found that a single intravenous dose of DMT rapidly reduced depressive symptoms versus placebo in adults with moderate to severe depression. Improvements ...

A new study explores exercise mimetics as novel therapeutics for depression by triggering muscle-to-brain signals that support mood regulation and resilience.

For the many patients with depression who haven't found relief through medication, transcranial magnetic stimulation (TMS)—a ...

People on Ozempic and similar drugs are spontaneously starting to exercise — not because anyone told them to, but because neuroscientists believe these medications are quietly rewiring how the brain ...

Luvesilocin is a subcutaneously-administered, proprietary prodrug of the psilocybin-like compound 4-OH-DiPT designed to target the serotonin 2A receptor.

Other cells, such as glial cells, support the function of neurons. Neuroscience has often painted glial cells as the glue ...